Your email has been successfully added to our mailing list.

×
-0.00011507479861909 -0.0680092059838896 -0.0621403912543154 -0.0996547756041427 -0.0449942462600691 -0.0736478711162256 -0.0485615650172612 -0.0517836593785961
Stock impact report

PaxMedica shares soar 125% post-market on drug update [Seeking Alpha]

PaxMedica, Inc. (PXMD) 
Company Research Source: Seeking Alpha
registration/validation batches of its drug PAX-101, an IV formulation of the drug suramin. The biotech company said the batches will help enable the company to file for FDA approval of the product for the treatment of Stage 1 Human African Trypanosomiasis, or HAT, which is caused by the fatal tropical disease Trypanosoma brucei rhodesiense. PaxMedica plans to file a new drug application for PAX-101 in Q4. The company also hopes to advance the product into clinical testing for the treatment of core symptoms of Autism Spectrum Disorder, according to a statement Recommended For You More Trending News Recommended For You More Trending News About PXMD Stock Related Stocks Trending Analysis Trending News Show less Read more
Impact Snapshot
Event Time:
PXMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
PXMD alerts

from News Quantified
Opt-in for
PXMD alerts

from News Quantified